Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ornella Corazza

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Substance Use & Misuse|April 20, 2010
Near-death states reported in a sample of 50 misusersOrnella Corazza, Fabrizio Schifano
CNS Neuroscience & Therapeutics|February 21, 2013
From "Special K" to "Special M": the evolution of the recreational use of ketamine and methoxetamineOrnella Corazza, Sulaf Assi, Fabrizio Schifano
Human Psychopharmacology|July 29, 2015
Detecting a signal in the noise: monitoring the global spread of novel psychoactive substances using media and other open-source informationMatthew M Young, Chad Dubeau, Ornella Corazza
Current Opinion in Psychiatry|May 14, 2020
Global strategy for New Psychoactive Substances: an updateBalasingam Vicknasingam, Suresh Narayanan, Darshan Singh, et al.
Iranian Journal of Public Health|June 27, 2013
Novel Psychoactive Substances (NPS): a Study on Persian Language WebsitesImanollah Bigdeli, Ornella Corazza, Zoe Aslanpour, et al.
Journal of Mental Health (Abingdon, England)|July 25, 2012
e-Psychonauts: conducting research in online drug forum communitiesZoe Davey, Fabrizio Schifano, Ornella Corazza, et al.
Brain Sciences|May 15, 2018
Transitioning Bodies. The Case of Self-Prescribing Sexual Hormones in Gender Affirmation in Individuals Attending Psychiatric ServicesAntonio Metastasio, Attilio Negri, Giovanni Martinotti, et al.
Journal of Psychoactive Drugs|February 7, 2020
Uses, Effects and Toxicity of Synthetic Cannabinoids from the Perspective of People with Lived ExperiencesSulaf Assi, Danielle Marshall, Francesco Saverio Bersani, et al.
Human Psychopharmacology|June 21, 2017
Impact of synthetic cannabinoids on the duration of opioid-related withdrawal and craving among patients of addiction clinics in Kazakhstan: A prospective case-control studyMariya Prilutskaya, Francesco Saverio Bersani, Ornella Corazza, et al.
Human Psychopharmacology|June 21, 2017
The risk of violence associated with novel psychoactive substance misuse in patients presenting to acute mental health servicesAbu Shafi, Paul Gallagher, Neil Stewart, et al.
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Substance Use & Misuse|April 20, 2010
Near-death states reported in a sample of 50 misusersOrnella Corazza, Fabrizio Schifano
CNS Neuroscience & Therapeutics|February 21, 2013
From "Special K" to "Special M": the evolution of the recreational use of ketamine and methoxetamineOrnella Corazza, Sulaf Assi, Fabrizio Schifano
Human Psychopharmacology|July 29, 2015
Detecting a signal in the noise: monitoring the global spread of novel psychoactive substances using media and other open-source informationMatthew M Young, Chad Dubeau, Ornella Corazza
Current Opinion in Psychiatry|May 14, 2020
Global strategy for New Psychoactive Substances: an updateBalasingam Vicknasingam, Suresh Narayanan, Darshan Singh, et al.
Iranian Journal of Public Health|June 27, 2013
Novel Psychoactive Substances (NPS): a Study on Persian Language WebsitesImanollah Bigdeli, Ornella Corazza, Zoe Aslanpour, et al.
Journal of Mental Health (Abingdon, England)|July 25, 2012
e-Psychonauts: conducting research in online drug forum communitiesZoe Davey, Fabrizio Schifano, Ornella Corazza, et al.
Brain Sciences|May 15, 2018
Transitioning Bodies. The Case of Self-Prescribing Sexual Hormones in Gender Affirmation in Individuals Attending Psychiatric ServicesAntonio Metastasio, Attilio Negri, Giovanni Martinotti, et al.
Journal of Psychoactive Drugs|February 7, 2020
Uses, Effects and Toxicity of Synthetic Cannabinoids from the Perspective of People with Lived ExperiencesSulaf Assi, Danielle Marshall, Francesco Saverio Bersani, et al.
Human Psychopharmacology|June 21, 2017
Impact of synthetic cannabinoids on the duration of opioid-related withdrawal and craving among patients of addiction clinics in Kazakhstan: A prospective case-control studyMariya Prilutskaya, Francesco Saverio Bersani, Ornella Corazza, et al.
Human Psychopharmacology|June 21, 2017
The risk of violence associated with novel psychoactive substance misuse in patients presenting to acute mental health servicesAbu Shafi, Paul Gallagher, Neil Stewart, et al.
Pageof 11